Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
We evaluated healthcare facility use of (ICD-10) codes for culture-confirmed candidemia cases detected by active public health surveillance during 2019-2020. Most cases (56%) did not receive a candidiasis code, suggesting that studies relying on ICD-10 codes likely underestimate disease burden.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9522671 | PMC |
| http://dx.doi.org/10.1093/ofid/ofac461 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Candida auris infections in ICU patients: risk factors, outcomes, and antifungal resistance patterns.
Crit Care
July 2025
Dept of Critical Care Medicine, IMS & SUM Hospital, Bhubaneswar, Odisha, India.
Background: has emerged as a major nosocomial pathogen in intensive care units worldwide due to its multidrug resistance, environmental persistence, and high transmission potential. While several outbreak reports exist, there remains limited comparative data on clinical features, resistance profiles, and outcomes between and non-auris Candida candidemia, particularly in Indian ICU settings. This study aimed to evaluate the incidence, risk factors, antifungal resistance, and clinical outcomes of bloodstream infections in comparison to non-auris Candida infections among ICU patients.
View Article and Find Full Text PDFProblem/condition: Candidemia, a bloodstream infection caused by Candida spp., is a common cause of health care-associated bloodstream infections in the United States. Candidemia is associated with substantial health care costs, morbidity, and mortality.
View Article and Find Full Text PDFLow Sensitivity of Coding for Culture-Confirmed Candidemia Cases in an Active Surveillance System: United States, 2019-2020.
Open Forum Infect Dis
September 2022
Division of Foodborne, Waterborne, and Environmental Diseases, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
We evaluated healthcare facility use of (ICD-10) codes for culture-confirmed candidemia cases detected by active public health surveillance during 2019-2020. Most cases (56%) did not receive a candidiasis code, suggesting that studies relying on ICD-10 codes likely underestimate disease burden.
View Article and Find Full Text PDFCombined Use of Presepsin and (1,3)-β-D-glucan as Biomarkers for Diagnosing Sepsis and Monitoring the Effectiveness of Treatment in Critically Ill Patients.
J Fungi (Basel)
March 2022
Department of Immunology, Faculty of Medicine and Dentistry, Palacký University Olomouc, 775 15 Olomouc, Czech Republic.
New biomarker panel was developed and validated on 165 critically ill adult patients to enable a more accurate invasive candidiasis (IC) diagnosis. Serum levels of the panfungal biomarker (1,3)-β-D-glucan (BDG) and the inflammatory biomarkers C-reactive protein, presepsin (PSEP), and procalcitonin (PCT) were correlated with culture-confirmed candidemia or bacteremia in 58 and 107 patients, respectively. The diagnostic utility was evaluated in sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV).
View Article and Find Full Text PDFWe determined the effect of HIV infection on deaths among persons >18 months of age with culture-confirmed candidemia at 29 sentinel hospitals in South Africa during 2012-2017. Of 1,040 case-patients with documented HIV status and in-hospital survival data, 426 (41%) were HIV-seropositive. The in-hospital case-fatality rate was 54% (228/426) for HIV-seropositive participants and 37% (230/614) for HIV-seronegative participants (crude odds ratio [OR] 1.
View Article and Find Full Text PDF